Back to
RTW INVESTMENTS, LP
URGN20 quarters
Position history for
RTW INVESTMENTS, LP's holdings in UROGEN PHARMA LTD
Yes. RTW Investments holds 4,543,895 shares of URGN (Urogen Pharma), worth $167.2M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. RTW Investments has held URGN since Q3 2021, across 20 quarterly 13F filings. URGN is 1.4% of RTW Investments' reported 13F portfolio.
Current Value
$167.2M
Current Shares
4.5M
Total Value Change
+$152.8M
Total Shares Change
+3.7M
Quarter-by-Quarter History
Other major holders of URGN: BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD., MORGAN STANLEY